Prof. Heerspink: DAPA-CKD and Use of Dapagliflozin

September 03, 2020

A podcast featuring the presenter of DAPA-CKD discussing results of the trial and how they inform use of dapagliflozin in patients with chronic kidney disease with and without type 2 diabetes.

Joshua Denson, MD: Impact of Metabolic Syndrome in COVID-19 Patients

September 02, 2020

A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals.

The Impact of COVID-19 on Diabetes Research

August 05, 2020

A medical researcher from the UK discusses how the ongoing pandemic has impacted diabetes research and how researchers have had to adapt during an uncertain time.

Robert Busch, MD: Reaction to EMPEROR-REDUCED Topline Results

August 01, 2020

An endocrinologist offers perspective on his reaction to EMPEROR-REDUCED topline results and what he hopes to see from the full results at ESC 2020.